181 related articles for article (PubMed ID: 25941132)
1. Analysis of prognostic risk factors in children with Epstein-Barr virus-associated hemophagocytic syndrome.
Xue H; Chen C; Li W; Lin C; Fang J; Li Y; Xu H
Minerva Pediatr; 2015 Jun; 67(3):251-61. PubMed ID: 25941132
[TBL] [Abstract][Full Text] [Related]
2. [Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].
Lu G; Xie ZD; Shen KL; Wu RH; Jin YK; Yang S; Liu CY
Zhonghua Er Ke Za Zhi; 2010 Feb; 48(2):121-6. PubMed ID: 20426937
[TBL] [Abstract][Full Text] [Related]
3. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol].
Xiao L; Xian Y; Dai BT; Su YC; Xiao JW; Zheng QC; Zhao XD; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group.
Kogawa K; Sato H; Asano T; Ohga S; Kudo K; Morimoto A; Ohta S; Wakiguchi H; Kanegane H; Oda M; Ishii E
Pediatr Blood Cancer; 2014 Jul; 61(7):1257-62. PubMed ID: 24535916
[TBL] [Abstract][Full Text] [Related]
5. [Clinical analysis of Epstein-Barr virus-associated hemophagocytic syndrome in children].
Guo X; Li Q; Zhou CY; Zhao YN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):460-4. PubMed ID: 23628054
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.
Chellapandian D; Das R; Zelley K; Wiener SJ; Zhao H; Teachey DT; Nichols KE;
Br J Haematol; 2013 Aug; 162(3):376-82. PubMed ID: 23692048
[TBL] [Abstract][Full Text] [Related]
7. Malignancy-associated hemophagocytic lymphohistiocytosis in children: a 10-year experience of a single pediatric hematology center.
Huang Z; Jia Y; Zuo Y; Wu J; Lu A; Zhang L
Hematology; 2020 Dec; 25(1):389-399. PubMed ID: 33161882
[No Abstract] [Full Text] [Related]
8. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults and adolescents-a life-threatening disease: analysis of 133 cases from a single center.
Lai W; Wang Y; Wang J; Wu L; Jin Z; Wang Z
Hematology; 2018 Dec; 23(10):810-816. PubMed ID: 29957156
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: a retrospective study of 78 pediatric cases in mainland of China.
Jin YK; Xie ZD; Yang S; Lu G; Shen KL
Chin Med J (Engl); 2010 Jun; 123(11):1426-30. PubMed ID: 20819601
[TBL] [Abstract][Full Text] [Related]
10. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Shiraishi A; Ohga S; Doi T; Ishimura M; Takimoto T; Takada H; Miyamoto T; Abe Y; Hara T
Pediatr Blood Cancer; 2012 Aug; 59(2):265-70. PubMed ID: 22183955
[TBL] [Abstract][Full Text] [Related]
11. Requirement for etoposide in the initial treatment of Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis.
Song Y; Wang Y; Wang Z
Br J Haematol; 2019 Sep; 186(5):717-723. PubMed ID: 31115044
[TBL] [Abstract][Full Text] [Related]
12. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
[TBL] [Abstract][Full Text] [Related]
13. Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol.
Yanagaisawa R; Matsuda K; Ohga S; Kanegane H; Morimoto A; Okamoto Y; Ohara A; Fukushima K; Sotomatsu M; Nomura K; Saito AM; Horibe K; Ishii E; Nakazawa Y
Int J Hematol; 2019 May; 109(5):612-617. PubMed ID: 30788725
[TBL] [Abstract][Full Text] [Related]
14. Assessment of immunochemotherapy and stem cell transplantation on EBV-associated hemophagocytic lymphohistiocytosis in children: a systematic review and meta analysis.
Qin Q; Xie Z; Shen Y; Yang S; Liu C; Huang Z; Xu J; Al J; Shen K
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):672-8. PubMed ID: 22774410
[TBL] [Abstract][Full Text] [Related]
15. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin.
Beutel K; Gross-Wieltsch U; Wiesel T; Stadt UZ; Janka G; Wagner HJ
Pediatr Blood Cancer; 2009 Aug; 53(2):184-90. PubMed ID: 19353621
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and outcomes of patients with hemophagocytic lymphohistiocytosis at onset of systemic autoinflammatory disorder and compare with Epstein-Barr virus (EBV)-related hemophagocytic lymphohistiocytosis.
Zhao Y; Li Z; Zhang L; Lian H; Ma H; Wang D; Zhao X; Zhang Q; Wang T; Zhang R
Medicine (Baltimore); 2020 Jan; 99(1):e18503. PubMed ID: 31895784
[TBL] [Abstract][Full Text] [Related]
17. Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents.
Lehmberg K; Sprekels B; Nichols KE; Woessmann W; Müller I; Suttorp M; Bernig T; Beutel K; Bode SF; Kentouche K; Kolb R; Längler A; Minkov M; Schilling FH; Schmid I; Vieth S; Ehl S; Zur Stadt U; Janka GE
Br J Haematol; 2015 Aug; 170(4):539-49. PubMed ID: 25940575
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
Ohga S; Kudo K; Ishii E; Honjo S; Morimoto A; Osugi Y; Sawada A; Inoue M; Tabuchi K; Suzuki N; Ishida Y; Imashuku S; Kato S; Hara T
Pediatr Blood Cancer; 2010 Feb; 54(2):299-306. PubMed ID: 19827139
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of clonality and Epstein-Barr virus infection in adult patients with hemophagocytic lymphohistiocytosis.
Ahn JS; Rew SY; Shin MG; Kim HR; Yang DH; Cho D; Kim SH; Bae SY; Lee SR; Kim YK; Kim HJ; Lee JJ
Am J Hematol; 2010 Sep; 85(9):719-22. PubMed ID: 20652965
[TBL] [Abstract][Full Text] [Related]
20. L-DEP regimen salvage therapy for paediatric patients with refractory Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis.
Zhao Y; Li Z; Zhang L; Lian H; Ma H; Wang D; Zhao X; Zhang Q; Wang T; Zhang R
Br J Haematol; 2020 Nov; 191(3):453-459. PubMed ID: 32525580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
